Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice

In adoptive T cell therapy (ACT), the transfer of tumor-specific T cells is paralleled by the conditioning regimen to increase therapeutic efficacy. Pre-conditioning depletes immune-suppressive cells and post-conditioning increases homeostatic signals to improve the persistence of administered T cel...

Full description

Bibliographic Details
Main Authors: Seon-Hee Kim, Eun Mi Go, Dong Hoon Shin, Beom K. Choi, Chungyong Han
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/11/23/3894
_version_ 1797463446868983808
author Seon-Hee Kim
Eun Mi Go
Dong Hoon Shin
Beom K. Choi
Chungyong Han
author_facet Seon-Hee Kim
Eun Mi Go
Dong Hoon Shin
Beom K. Choi
Chungyong Han
author_sort Seon-Hee Kim
collection DOAJ
description In adoptive T cell therapy (ACT), the transfer of tumor-specific T cells is paralleled by the conditioning regimen to increase therapeutic efficacy. Pre-conditioning depletes immune-suppressive cells and post-conditioning increases homeostatic signals to improve the persistence of administered T cells. Identifying the favorable immunological factors involved in a conditioning regimen is important to design effective strategies in ACT. Here, by using an ACT model of murine melanoma, we evaluate the effect of the total body irradiation (TBI) and interleukin-2 (IL-2) treatment combination. The use of a <i>Rag1</i> knock-out strain, which lacks endogenous T cells, enables the identification of factors in a way that focuses more on transferred T cells. We demonstrate that the TBI/IL-2 combination has no additive effect in ACT, although each conditioning improves the therapeutic outcome. While the combination increases the frequency of transferred T cells in lymphoid and tumor tissues, the activation intensity of the cells is reduced compared to that of the sole TBI treatment. Notably, we show that in the presence of TBI, the IL-2 treatment reduces the frequency of intra-tumoral dendritic cells, which are crucial for T cell activation. The current study provides insights into the immunological events involved in the TBI/IL-2 combination in ACT.
first_indexed 2024-03-09T17:50:49Z
format Article
id doaj.art-daca389f90da491ab7fda84b61f2239e
institution Directory Open Access Journal
issn 2073-4409
language English
last_indexed 2024-03-09T17:50:49Z
publishDate 2022-12-01
publisher MDPI AG
record_format Article
series Cells
spelling doaj.art-daca389f90da491ab7fda84b61f2239e2023-11-24T10:45:35ZengMDPI AGCells2073-44092022-12-011123389410.3390/cells11233894Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out MiceSeon-Hee Kim0Eun Mi Go1Dong Hoon Shin2Beom K. Choi3Chungyong Han4Immuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of KoreaImmuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of KoreaTargeted Therapy Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of KoreaBiomedicine Production Branch, Cancer Immunotherapy Working Group, Research Institute, National Cancer Center, Goyang 10408, Republic of KoreaImmuno-Oncology Branch, Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang 10408, Republic of KoreaIn adoptive T cell therapy (ACT), the transfer of tumor-specific T cells is paralleled by the conditioning regimen to increase therapeutic efficacy. Pre-conditioning depletes immune-suppressive cells and post-conditioning increases homeostatic signals to improve the persistence of administered T cells. Identifying the favorable immunological factors involved in a conditioning regimen is important to design effective strategies in ACT. Here, by using an ACT model of murine melanoma, we evaluate the effect of the total body irradiation (TBI) and interleukin-2 (IL-2) treatment combination. The use of a <i>Rag1</i> knock-out strain, which lacks endogenous T cells, enables the identification of factors in a way that focuses more on transferred T cells. We demonstrate that the TBI/IL-2 combination has no additive effect in ACT, although each conditioning improves the therapeutic outcome. While the combination increases the frequency of transferred T cells in lymphoid and tumor tissues, the activation intensity of the cells is reduced compared to that of the sole TBI treatment. Notably, we show that in the presence of TBI, the IL-2 treatment reduces the frequency of intra-tumoral dendritic cells, which are crucial for T cell activation. The current study provides insights into the immunological events involved in the TBI/IL-2 combination in ACT.https://www.mdpi.com/2073-4409/11/23/3894adoptive T cell therapytotal body irradiationinterleukin-2melanoma<i>Rag1</i> knock-out micedendritic cell
spellingShingle Seon-Hee Kim
Eun Mi Go
Dong Hoon Shin
Beom K. Choi
Chungyong Han
Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
Cells
adoptive T cell therapy
total body irradiation
interleukin-2
melanoma
<i>Rag1</i> knock-out mice
dendritic cell
title Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
title_full Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
title_fullStr Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
title_full_unstemmed Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
title_short Pro- and Anti-Tumoral Factors Involved in Total Body Irradiation and Interleukin-2 Conditioning in Adoptive T Cell Therapy of Melanoma-Bearing <i>Rag1</i> Knock-Out Mice
title_sort pro and anti tumoral factors involved in total body irradiation and interleukin 2 conditioning in adoptive t cell therapy of melanoma bearing i rag1 i knock out mice
topic adoptive T cell therapy
total body irradiation
interleukin-2
melanoma
<i>Rag1</i> knock-out mice
dendritic cell
url https://www.mdpi.com/2073-4409/11/23/3894
work_keys_str_mv AT seonheekim proandantitumoralfactorsinvolvedintotalbodyirradiationandinterleukin2conditioninginadoptivetcelltherapyofmelanomabearingirag1iknockoutmice
AT eunmigo proandantitumoralfactorsinvolvedintotalbodyirradiationandinterleukin2conditioninginadoptivetcelltherapyofmelanomabearingirag1iknockoutmice
AT donghoonshin proandantitumoralfactorsinvolvedintotalbodyirradiationandinterleukin2conditioninginadoptivetcelltherapyofmelanomabearingirag1iknockoutmice
AT beomkchoi proandantitumoralfactorsinvolvedintotalbodyirradiationandinterleukin2conditioninginadoptivetcelltherapyofmelanomabearingirag1iknockoutmice
AT chungyonghan proandantitumoralfactorsinvolvedintotalbodyirradiationandinterleukin2conditioninginadoptivetcelltherapyofmelanomabearingirag1iknockoutmice